FindTrial
Sign In

The effect of intrauterine Lidocaine instillation on pain scores in hysteroscopic guided biopsy

The effect of intrauterine Lidocaine instillation on pain scores among women undergoing hysteroscopic guided biopsy: a double blind randomized placebo controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034679
Enrollment
126
Registered
2021-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Intrauterine anaesthesia group: receive intrauterine 5mL oflidocaine 2% undiluted before hysteroscopy. Control Intervention1: Placebo group: receive intrauterine 5 ml normal saline befo

Sponsors

JIPMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women aged 18 years who need hysteroscopy guided biopsy.

Exclusion criteria

Exclusion criteria: Pregnant women ii) Women with pelvic inflammatory diseases iii) Women with hypersensitivity to lidocaine iv) History of cardiac disease, seizure disorder or bleeding disorder. v) Previous history of cervical surgery. vi) If cervical priming is used

Design outcomes

Primary

MeasureTime frame
To compare the VAS score for pain in women receiving intrauterine anesthesia with those receiving placebo during hysteroscopic guided biopsy.Timepoint: 3 years—

Secondary

MeasureTime frame
a)To compare VAS score and patient satisfaction between the women receiving intrauterine anesthesia compared to placebo in the post operative period. b)To evaluate complications, if any, associated with intrauterine anesthesia.Timepoint: 3 years—

Countries

India

Contacts

Public ContactDrAishwarya T P

JIPMER, Puducherry

muralidraiims@gmail.com8940760837

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026